Colloids Surf B Biointerfaces
February 2025
Approximately 5-10 % of fractures are associated with non-union, posing a significant challenge in orthopedic applications. Addressing this issue, innovative approaches beyond traditional grafting techniques like bone tissue engineering (BTE) are required. Biomaterials, combined with cells and bioactive molecules in BTE, are critical in managing non-union.
View Article and Find Full Text PDFBone tissue engineering (BTE) offers promising strategies for bone regeneration, yet the effective delivery of bioactive molecules remains a challenge. Khellin (KH), a plant-derived furanochromone, possesses various biological properties, though its potential in promoting osteogenesis has not been thoroughly investigated. In this study, 3D-printed polylactic acid (PLA) scaffolds were integrated with KH-loaded chitosan-alginate sponges (PLA/ALG/CS-KH) to facilitate controlled and sustained delivery of KH.
View Article and Find Full Text PDFInt J Biol Macromol
January 2025
Bone tissue engineering (BTE) is an emerging strategy for the treatment of critical bone defects using biomaterials and cells. Esculetin (ES), a coumarin phytocompound, has demonstrated therapeutic potential, although its osteogenic effects remain insufficiently explored. Owing to its hydrophobic nature, which limits its bioavailability, this study developed a drug delivery system using chitosan nanoparticles (nCS) to achieve sustained release of ES.
View Article and Find Full Text PDFBone tissue engineering (BTE) aims to develop implantable bone replacements for severe skeletal abnormalities that do not heal. In the field of BTE, chitosan (CS) has become a leading polysaccharide in the development of bone scaffolds. Although CS has several excellent properties, such as biodegradability, biocompatibility, and antibacterial properties, it has limitations for use in BTE because of its poor mechanical properties, increased degradation, and minimal bioactivity.
View Article and Find Full Text PDF